GE HealthCare Technologies Inc. (NASDAQ:GEHC) Shares Sold by HighPoint Advisor Group LLC

HighPoint Advisor Group LLC trimmed its holdings in GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 1.0% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 37,140 shares of the company’s stock after selling 380 shares during the period. HighPoint Advisor Group LLC’s holdings in GE HealthCare Technologies were worth $3,067,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. CoreFirst Bank & Trust acquired a new stake in shares of GE HealthCare Technologies in the fourth quarter worth approximately $25,000. Runnymede Capital Advisors Inc. purchased a new position in GE HealthCare Technologies during the fourth quarter worth approximately $28,000. Continuum Advisory LLC boosted its holdings in shares of GE HealthCare Technologies by 101.8% in the 3rd quarter. Continuum Advisory LLC now owns 333 shares of the company’s stock valued at $31,000 after purchasing an additional 168 shares during the last quarter. Bank of Jackson Hole Trust acquired a new position in shares of GE HealthCare Technologies in the 4th quarter valued at $32,000. Finally, OFI Invest Asset Management purchased a new stake in shares of GE HealthCare Technologies during the 4th quarter valued at $34,000. Hedge funds and other institutional investors own 82.06% of the company’s stock.

Wall Street Analysts Forecast Growth

Several research analysts recently weighed in on GEHC shares. Jefferies Financial Group raised GE HealthCare Technologies from a “hold” rating to a “buy” rating and increased their target price for the stock from $95.00 to $103.00 in a research report on Wednesday, January 8th. Citigroup raised their price objective on GE HealthCare Technologies from $103.00 to $110.00 and gave the stock a “buy” rating in a report on Thursday, February 13th. The Goldman Sachs Group raised GE HealthCare Technologies from a “neutral” rating to a “buy” rating and lifted their price objective for the company from $85.00 to $100.00 in a research note on Tuesday, March 11th. Finally, Wells Fargo & Company increased their target price on shares of GE HealthCare Technologies from $96.00 to $103.00 and gave the stock an “overweight” rating in a research report on Friday, February 14th. One analyst has rated the stock with a sell rating, two have issued a hold rating, nine have issued a buy rating and one has assigned a strong buy rating to the stock. According to MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average target price of $98.75.

GE HealthCare Technologies Price Performance

Shares of GEHC stock opened at $80.71 on Tuesday. The firm has a fifty day simple moving average of $86.62 and a 200-day simple moving average of $85.81. The company has a market capitalization of $36.91 billion, a PE ratio of 18.64, a price-to-earnings-growth ratio of 3.19 and a beta of 1.13. GE HealthCare Technologies Inc. has a twelve month low of $74.51 and a twelve month high of $94.80. The company has a current ratio of 1.04, a quick ratio of 0.83 and a debt-to-equity ratio of 0.88.

GE HealthCare Technologies (NASDAQ:GEHC) last posted its quarterly earnings data on Thursday, February 13th. The company reported $1.45 earnings per share for the quarter, beating analysts’ consensus estimates of $1.26 by $0.19. GE HealthCare Technologies had a net margin of 10.13% and a return on equity of 25.74%. The company had revenue of $5.32 billion during the quarter, compared to analysts’ expectations of $5.33 billion. Equities research analysts anticipate that GE HealthCare Technologies Inc. will post 4.68 earnings per share for the current fiscal year.

GE HealthCare Technologies Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, May 15th. Shareholders of record on Friday, April 25th will be issued a dividend of $0.035 per share. The ex-dividend date is Friday, April 25th. This represents a $0.14 annualized dividend and a yield of 0.17%. GE HealthCare Technologies’s dividend payout ratio is presently 3.23%.

GE HealthCare Technologies Company Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.